Insulet Corporation

Insulet Corporation

World Rank (Aug-2026)
2221
Market Cap (Aug-2026)
9.941 Billion USD
World Rank (Jan-05-2024)
1,260
Market Cap (Jan-05-2024)
13.952 Billion USD
World Rank (Jul-30-2023)
945
Market Cap (Jul-30-2023)
19.552 Billion USD
World Rank (Jan-07-2022)
1,180
Market Cap (Jan-07-2022)
17.247 Billion USD
World Rank (Jan-01-2021)
1,063
Market Cap (Jan-01-2021)
16.853 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 390
Headquarters Country
USA
Top Healthcare Companies in USA
Nasdaq / NYSE Code
PODD
CEO
Shacey Petrovic
Employee Count
2,600
Employee Count as of Date
As on 2022
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
2,708 Million USD
Annual Operating Income in USD
474 Million USD
Annual Net Income in USD
247 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
3,190 Million USD
Total Liabilities in USD
1,675 Million USD
Total Equity in USD
1,515 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Medical Equipment / Instruments
HealthCare Products
Company Website
INSULET CORPORATION
Yahoo
Yahoo @ Nasdaq
Facebook
Facebook
Company Profile

INSULET CORPORATION is Medical equipment manufacturing company with headquarters is in Massachusetts, USA.Medical equipment manufacturing company with headquarters is in Massachusetts, USA.
Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier. 
It is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. Omnipod provides a unique alternative to traditional insulin delivery methods. 
The Omnipod is a revolutionary and easy-to-use tubeless insulin pump that provides up to three days of non-stop insulin delivery, without the need to see or handle a needle.
 

Facts About Company

As of 2022, INSULET CORPORATION has 2,600 employees.
INSULET CORPORATION annual revenue generated for period ending Dec-2022 was 1,305 million USD.
INSULET CORPORATION annual net income generated for period ending Dec-2022 was 4 million USD.

Annual Results Summary

INSULET CORPORATION - Annual Results Summary - in Million USD

Year Ending:Total RevenueGross ProfitOperating IncomeNet Income
Dec-20231,6971,159220206
Dec-20221,305805374
Dec-20211,09875212616
Dec-2020904582516
Dec-20197384805011
Dec-2018564370273
Dec-2017463277.2(7.4) (Loss)(26.8) (Loss)
Dec-2016367211.1(10.7) (Loss)(28.9) (Loss)
Balance Sheet Summary

Total Assets as on Dec-2023 was 2,588 Million USD.

Total Liabilities as on Dec-2023 was 1,855 Million USD.

Total Equity as on Dec-2023 was 732 Million USD.

Founded Year
2000
IPO Year
2007
Stock Category
S&P 500
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Medical/Dental Instruments

Share